Assessment of variants associated with resistance in NS3, NS5A and NS5B region in genotype 1b HCV infected patients
Not Applicable
- Conditions
- patients infected with genotype 1 HCV
- Registration Number
- JPRN-UMIN000018857
- Lead Sponsor
- Department of Gastroenterology & Hepatology, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
patients infected with HCV other than genotype 1
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the efficacy of antiviral therapy at post-treatment 12 and 24 weeks
- Secondary Outcome Measures
Name Time Method